Rezolute, Inc. — Investor Relations & Filings
Filings indexed
720
across all filing types
Latest filing
2026-03-26
Major Shareholding Noti…
Country
US
United States of America
Listing
US
RZLT
Rezolute, Inc. is a late-stage biopharmaceutical company dedicated to developing therapies for rare diseases. The company's primary focus is on addressing hypoglycemia caused by hyperinsulinism (HI). Its lead product candidate, ersodetug, is being developed as a potential treatment for hypoglycemia related to both congenital and tumor-induced hyperinsulinism. Rezolute is advancing ersodetug through two ongoing Phase 3 clinical trials for these indications, aiming to provide a novel therapeutic option for patients with significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A - Rezolute, Inc. (0001509261) (Subject) | 2026-03-26 | English | |
| 8-K - Rezolute, Inc. (0001509261) (Filer) | 2026-03-24 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| 8-K - REZOLUTE, INC. (0001509261) (Filer) | 2026-02-12 | English | |
| 10-Q Filing | 2026-02-12 | English | |
| SCHEDULE 13G Filing | 2026-01-30 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 33050165 | SCHEDULE 13G/A - Rezolute, Inc. (0001509261) (Subject) | 2026-03-26 | English | ||
| 33028716 | 8-K - Rezolute, Inc. (0001509261) (Filer) | 2026-03-24 | English | ||
| 30226787 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32892933 | 8-K - REZOLUTE, INC. (0001509261) (Filer) | 2026-02-12 | English | ||
| 30226912 | 10-Q Filing | 2026-02-12 | English | ||
| 30226767 | SCHEDULE 13G Filing | 2026-01-30 | English | ||
| 12414222 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
| 12414221 | FORM 8-K | 2026-01-07 | English | ||
|
2025
7 filings
| |||||
| 12414223 | Major Shareholding Notification 2025 | 2025-12-19 | English | ||
| 12414224 | Major Shareholding Notification 2025 | 2025-12-18 | English | ||
| 12414225 | FORM 4 | 2025-12-17 | English | ||
| 12414226 | FORM 4 | 2025-12-17 | English | ||
| 12414227 | FORM 4 | 2025-12-16 | English | ||
| 12414228 | FORM 4 | 2025-12-16 | English | ||
| 12414229 | FORM 4 | 2025-12-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
Rezolute, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32362/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32362 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32362 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32362 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32362}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Rezolute, Inc. (id: 32362)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.